Because AD is often referred to as “type 3 diabetes” due to its association with insulin resistance and IGF gene abnormalities, the ability of DHEA/DHEA-S to enhance insulin sensitivity and secretion may help reduce the risk of dementia [53,54]. This evidence concerns the gene IGF1 and Insulin resistance.